| 2025 | 2024 | 2023 | 2022 | 2021 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross margin | 109,7 k € | -15.7% | 130,2 k € | -0.6% | 130,9 k € | +4.9% | 124,8 k € | -16.9% | 150,2 k € | +60.2% | 93,7 k € | +0.9% | 92,9 k € | +90.0% | 48,9 k € | +256.4% | -31,3 k € | -556.6% | -4,8 k € | -104.7% | 100,5 k € | +28.3% | 78,4 k € | -18.6% | 96,3 k € | -1.3% | 97,6 k € | -4.8% | 102,5 k € | -17.0% | 123,5 k € | -0.4% | 124,0 k € | +36.4% | 90,9 k € | |
| EBITDA | 108,6 k € | -15.9% | 129,0 k € | -0.4% | 129,6 k € | +4.7% | 123,8 k € | -17.0% | 149,2 k € | +60.8% | 92,8 k € | +0.6% | 92,2 k € | +91.2% | 48,2 k € | +250.6% | -32,0 k € | -1670.5% | 2,0 k € | -93.4% | 30,8 k € | +189.4% | 10,6 k € | -64.7% | 30,1 k € | +1.4% | 29,7 k € | -19.0% | 36,7 k € | -39.2% | 60,4 k € | -9.0% | 66,3 k € | +90.7% | 34,8 k € | |
| Operating profit | 63,1 k € | +2.3% | 61,7 k € | -8.9% | 67,8 k € | +6.7% | 63,5 k € | -30.6% | 91,5 k € | +156.4% | 35,7 k € | -1.6% | 36,3 k € | +730.3% | -5,8 k € | +89.3% | -54,0 k € | -17044.3% | 318,9 € | -98.6% | 22,8 k € | +2328.2% | -1,0 k € | -106.1% | 16,8 k € | -12.6% | 19,3 k € | +292.5% | 4,9 k € | -74.4% | 19,2 k € | -11.2% | 21,6 k € | +295.3% | -11,1 k € | |
| Profit/loss | 44,0 k € | +14.6% | 38,4 k € | -13.5% | 44,4 k € | +16.7% | 38,0 k € | -34.7% | 58,3 k € | +131.5% | 25,2 k € | +1.2% | 24,9 k € | +257.0% | -15,8 k € | +72.6% | -57,8 k € | -1033.5% | -5,1 k € | -134.4% | 14,8 k € | +271.1% | -8,7 k € | -216.0% | 7,5 k € | -24.8% | 9,9 k € | +294.7% | -5,1 k € | -187.4% | 5,8 k € | -45.6% | 10,7 k € | +187.4% | -12,3 k € | |
| Equity | 352,0 k € | +14.3% | 308,0 k € | +14.2% | 269,6 k € | +19.7% | 225,2 k € | +20.3% | 187,2 k € | +559.8% | 28,4 k € | +788.0% | 3,2 k € | +114.7% | -21,7 k € | -271.4% | -5,8 k € | -111.2% | 52,0 k € | -8.9% | 57,1 k € | +35.1% | 42,2 k € | -17.0% | 50,9 k € | +17.2% | 43,4 k € | +29.6% | 33,5 k € | -13.2% | 38,6 k € | +17.8% | 32,8 k € | +48.6% | 22,0 k € | |
| Total assets | 478,5 k € | -6.5% | 511,5 k € | +2.4% | 499,4 k € | +8.2% | 461,5 k € | +0.3% | 460,3 k € | -17.1% | 555,0 k € | -6.3% | 592,3 k € | -9.9% | 657,7 k € | +179.3% | 235,5 k € | +110.3% | 112,0 k € | -43.6% | 198,5 k € | +1.2% | 196,2 k € | -17.0% | 236,4 k € | +3.6% | 228,3 k € | -1.3% | 231,3 k € | -11.8% | 262,3 k € | +0.3% | 261,5 k € | -12.0% | 297,1 k € | |
| Cash | 244,5 k € | -4.6% | 256,2 k € | +54.0% | 166,4 k € | +32.9% | 125,2 k € | +14.5% | 109,3 k € | +17.0% | 93,4 k € | +51.3% | 61,8 k € | -33.2% | 92,4 k € | +862.3% | 9,6 k € | -90.4% | 99,7 k € | +19.9% | 83,1 k € | +74.3% | 47,7 k € | -30.4% | 68,6 k € | +27.4% | 53,8 k € | +46.2% | 36,8 k € | +13.2% | 32,5 k € | -6.5% | 34,8 k € | +48.3% | 23,5 k € | |
| Debts | 121,7 k € | -37.6% | 195,0 k € | -12.9% | 223,9 k € | -3.6% | 232,3 k € | -13.7% | 269,1 k € | -48.3% | 521,1 k € | -10.7% | 583,7 k € | -10.6% | 652,9 k € | +173.5% | 238,7 k € | +315.5% | 57,5 k € | -58.4% | 138,0 k € | -8.2% | 150,4 k € | -17.3% | 181,8 k € | +0.3% | 181,2 k € | -6.7% | 194,2 k € | -11.8% | 220,2 k € | -2.2% | 225,2 k € | -17.0% | 271,5 k € | |
| Staff | — | — | — | — | — | — | — | — | — | — | 0,8 | 0,8 | 0,8 | 0,8 | 0,8 | 0,8 | 0,8 | 0,8 | ||||||||||||||||||
Public limited company · Rumst · incorporated on 06/08/1999
Public limited company profitable and well capitalised.
Acceptable counterparty for a moderate engagement. Require 2 fiscal years of detailed accounts before any significant exposure. The abridged model hides revenue.
APOTHEEK TOBBACK is a Public limited company incorporated in 1999. Its main activity is: Dispensing chemist in specialised stores. Its registered office is in Rumst.
Key indicators
7-day free trial, no credit card required.
7-day free trial, no credit card required.
7-day free trial, no credit card required.
Source: Belgian Official Gazette